Hebei Derui Chemical Co., Ltd.’s new project in Wuhai has entered the implementation phase.

Release Date:

2018-09-11

Inner Mongolia Derui Biotechnology Co., Ltd., a wholly owned subsidiary of Hebei Derui Chemical Co., Ltd., was established on March 2, 2018. The project is designed to produce annually 10,000 tons of thiamethoxam, 20,000 tons of 2-chloro-5-(chloromethyl)thiazole, and 3,000 tons of clothianidin, with a total investment of RMB 559.005 million and a land area of 260 mu. On September 7, 2018, the project was reviewed by the Development and Reform Commission of Wuhai City, Inner Mongolia, and was found to comply with industrial policies and market access standards, thereby receiving approval for filing. Project number: 2018-150303-26-03-020974. Project construction site: Wuhai City, Hainan District, Wu.

Inner Mongolia Derui Biotechnology Co., Ltd., a wholly owned subsidiary of Hebei Derui Chemical Co., Ltd., on… 2018 year 3 month 2 Established on [date], the project is designed to have an annual output of [output]. 10000 tonnes of thiamethoxam, 20000 ton 2- Chlorine -5- Chloromethylthiazole, 3000 tonnes of thiamethoxam, total investment 55900.5 Ten thousand yuan, construction land 260 mu.

2018 year 9 month 7 Following review by the Development and Reform Commission of Wuhai City, Inner Mongolia, the project has been found to comply with industrial policies and market access standards and is hereby approved for filing.

Project Number: 2018-150303-26-03-020974

Project construction site: Wuhai City - Hainan District - Wuhai Economic Development Zone Low-Carbon Industrial Park